Quincy Medical Group (QMG) has been designated an Axonics Center of Excellence by Axonics Inc. The designation recognizes the QMG Urology team and specifically Matthew Knudson, MD, for his expertise with Axonics Therapy and sincere commitment to changing the lives of patients suffering from bladder and bowel dysfunction.

Today, millions of Americans suffer from overactive bladder and fecal incontinence. Axonics Therapy gently stimulates the sacral nerve (sacral neuromodulation), restoring normal communication between the brain and the bladder. Axonics Therapy has been clinically proven to provide rapid and long-lasting relief of symptoms associated with bladder and bowel dysfunction.

In a clinical study, 129 patients with urgency incontinence were treated with Axonics Therapy. At 2-years, 93% of patients had successful therapy and 94% of patients were satisfied with their therapy.

The Axonics Center of Excellence program recognizes highly trained and experienced physicians (typically urologists, urogynecologists, and colorectal surgeons) and clinical practices that are committed to patient education and providing exemplary care to achieve optimal clinical outcomes and patient satisfaction.

“Quincy Medical Group is proud to be recognized as a Center of Excellence. Axonics Therapy has shown remarkable promise in restoring quality of life for patients facing bladder and bowel dysfunction. This designation reflects the tireless efforts of our team to provide the best care possible,” said Dr. Knudson.

To learn more about Axonics Therapy at QMG, contact the QMG Urology team at (217) 222-6550, ext. 3894.